Thomas A. Satterfield, Jr. 13D/13G Filings for Cytosorbents Corporation (CTSO)

Thomas A. Satterfield, Jr. 13D and 13G filings for Cytosorbents Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-01-17
4:05 pm
Purchase
2025-01-1313GCytosorbents Corporation
CTSO
Thomas A. Satterfield, Jr.3,998,867
6.560%
3,998,867increase
(New Position)
Filing